ADMA Biologics DSO Ratio 2011-2026 | ADMA

Annual DSO Ratio ADMA Biologics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
74.6	33.1	30.3	52.2	94.3	114	43.2	29.9	62.2	34.9	47	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
114	29.9	56

Quarterly DSO Ratio ADMA Biologics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
84.1	78.2	59.4	-	30.6	33.9	42.9	-	46.1	48	33.7	-	44.2	59.9	85	-	96.9	99.5	81.3	-	118	155	74.7	-	43.8	48.3	62.9	31.3	30	27.3	59.5	-	74.9	104	85	-	31.6	40.9	41.7	-	45.5	64.4	39.7	-	25.6	23.4	11.2	-	-	20	21	-	9.9	15.5	406	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
406	9.9	62.7

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amgen AMGN	81.2	$ 350.13	2.98 %	$ 188 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Amneal Pharmaceuticals AMRX	55.7	$ 12.73	3.33 %	$ 3.99 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	8.82 %	$ 394 M	Britain
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	106	$ 24.57	5.59 %	$ 3.13 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.82	1.6 %	$ 9.19 B	Australia
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	150	$ 2.68	4.28 %	$ 16.8 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.05	0.66 %	$ 6.64 B	Israel
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Cerus Corporation CERS	47	$ 1.93	4.62 %	$ 368 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Coherus BioSciences CHRS	559	$ 1.73	3.59 %	$ 203 M	USA